Release Date: 26/10/22 09:21 Summary: 2022 Corporate Governance Statement Price Sensitive: No Download Document 216.11KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%